CD33 and cancer: Furthermore, CD36+ cancer-associated fibroblasts (CAFs) employ MIF and CD74 to attract CD33+ myeloid-derived suppressor cells (MDSCs), creating an immunosuppressive environment that facilitates immune evasion in hepatocellular carcinoma (31).